Evaluation of plasma Short chain fatty acid levels as markers for Inflammatory bowel disease
BACKGROUND: Specific variations of short chain fatty acids in fecal samples have been shown for patients with inflammatory bowel disease. The aim of this study was to assess if Crohn's disease and ulcerative colitis are associated with altered concentrations of short chain fatty acids also in blood plasma.
METHOD: Between 2016-2019, Swedish adults referred to a tertiary center for colonoscopy were asked to participate in a cross-sectional study. Individuals with Crohn's disease or ulcerative colitis as well as individuals with no findings on the colonoscopy (defined as clean colon) were included in the study. Data on colonoscopy findings, blood samples (including haemoglobin, C-reactive protein and short chain fatty acid analysis) as well as a validated lifestyle questionnaire including 277 questions were collected from all participants. Linear regression was used to compare mean concentrations of short chain fatty acids between Crohn's disease, ulcerative colitis and clean colon.
RESULTS: The cohort consisted of 132 individuals with Crohn's disease, 119 with ulcerative colitis and 205 with clean colon. In the crude model, succinic acid was significantly lower (p < 0.05) among patients with Crohn's disease (mean 3.00 µM SE 0.10) and ulcerative colitis (mean 3.13 µM SE 0.10) in comparison to clean colon (mean 3.41 µM SE 0.08), however when adjusting for sex, age and diet the results did not remain statistically significant. No differences in plasma concentration of the other measured short chain fatty acids were detected.
CONCLUSION: Crohn's disease and ulcerative colitis are not associated with altered short chain fatty acid concentrations in plasma. Further research is needed to confirm or refute our findings.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:58 |
---|---|
Enthalten in: |
Scandinavian journal of gastroenterology - 58(2023), 11 vom: 29. Juli, Seite 1246-1252 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kiasat, Ali [VerfasserIn] |
---|
Links: |
---|
Themen: |
Crohn’s disease |
---|
Anmerkungen: |
Date Completed 02.11.2023 Date Revised 03.11.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/00365521.2023.2219357 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM357747437 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM357747437 | ||
003 | DE-627 | ||
005 | 20231226073247.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/00365521.2023.2219357 |2 doi | |
028 | 5 | 2 | |a pubmed24n1192.xml |
035 | |a (DE-627)NLM357747437 | ||
035 | |a (NLM)37272725 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kiasat, Ali |e verfasserin |4 aut | |
245 | 1 | 0 | |a Evaluation of plasma Short chain fatty acid levels as markers for Inflammatory bowel disease |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 02.11.2023 | ||
500 | |a Date Revised 03.11.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a BACKGROUND: Specific variations of short chain fatty acids in fecal samples have been shown for patients with inflammatory bowel disease. The aim of this study was to assess if Crohn's disease and ulcerative colitis are associated with altered concentrations of short chain fatty acids also in blood plasma | ||
520 | |a METHOD: Between 2016-2019, Swedish adults referred to a tertiary center for colonoscopy were asked to participate in a cross-sectional study. Individuals with Crohn's disease or ulcerative colitis as well as individuals with no findings on the colonoscopy (defined as clean colon) were included in the study. Data on colonoscopy findings, blood samples (including haemoglobin, C-reactive protein and short chain fatty acid analysis) as well as a validated lifestyle questionnaire including 277 questions were collected from all participants. Linear regression was used to compare mean concentrations of short chain fatty acids between Crohn's disease, ulcerative colitis and clean colon | ||
520 | |a RESULTS: The cohort consisted of 132 individuals with Crohn's disease, 119 with ulcerative colitis and 205 with clean colon. In the crude model, succinic acid was significantly lower (p < 0.05) among patients with Crohn's disease (mean 3.00 µM SE 0.10) and ulcerative colitis (mean 3.13 µM SE 0.10) in comparison to clean colon (mean 3.41 µM SE 0.08), however when adjusting for sex, age and diet the results did not remain statistically significant. No differences in plasma concentration of the other measured short chain fatty acids were detected | ||
520 | |a CONCLUSION: Crohn's disease and ulcerative colitis are not associated with altered short chain fatty acid concentrations in plasma. Further research is needed to confirm or refute our findings | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Crohn’s disease | |
650 | 4 | |a Inflammatory bowel disease | |
650 | 4 | |a microbiota | |
650 | 4 | |a short-chain fatty acid | |
650 | 4 | |a ulcerative colitis | |
650 | 7 | |a Fatty Acids, Volatile |2 NLM | |
700 | 1 | |a Rautiainen, Susanne |e verfasserin |4 aut | |
700 | 1 | |a Prast-Nielsen, Stefanie |e verfasserin |4 aut | |
700 | 1 | |a Engstrand, Lars |e verfasserin |4 aut | |
700 | 1 | |a Schuppe-Koistinen, Ina |e verfasserin |4 aut | |
700 | 1 | |a Gustafsson, Ulf O |e verfasserin |4 aut | |
700 | 1 | |a Löf Granström, Anna |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Scandinavian journal of gastroenterology |d 1966 |g 58(2023), 11 vom: 29. Juli, Seite 1246-1252 |w (DE-627)NLM000055166 |x 1502-7708 |7 nnns |
773 | 1 | 8 | |g volume:58 |g year:2023 |g number:11 |g day:29 |g month:07 |g pages:1246-1252 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/00365521.2023.2219357 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 58 |j 2023 |e 11 |b 29 |c 07 |h 1246-1252 |